Lipella Pharmaceuticals Inc.
LIPO· Unspecified
LIPOLipella Pharmaceuticals Inc.
Filed May 9, 2024 · 10-Q · 39 days after period end · 0001753926-24-000943
| Metric | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|
| Revenue | $145.88K | $118.05K | $33.15K |
| Net Income | -$1.19M | -$1.07M | -$737.95K |
| EPS Diluted | -$1.31 | -$0.19 | -$0.19 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lipella Pharmaceuticals Inc. · CIK 1347242 · Engraved from SEC EDGAR
ended Mar 31, 2024 · filed May 9, 2024 · 39 d after period end
